Anaplastic thyroid cancer: Unveiling advances in diagnosis and management

doi:10.5306/wjco.v15.i7.786

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (788)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

577

Sum=602

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

110

Sum=139

Jul 24, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Jul 24, 2024; 15(7): 786-789
Published online Jul 24, 2024. doi: 10.5306/wjco.v15.i7.786

Anaplastic thyroid cancer: Unveiling advances in diagnosis and management

Treshita Dey, Budhi Singh Yadav

Treshita Dey, Budhi Singh Yadav, Department of Radiotherapy & Oncology, Post- Graduate Institute of Medical Education & Research, Chandigarh 160012, India

Author contributions: Yadav BS and Dey T contributed to conceptualization, literature review, manuscript writing, editing, and final approval.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Budhi Singh Yadav, MD, Professor, Department of Radiotherapy & Oncology, Post-Graduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India. drbudhi@gmail.com

Received: December 29, 2023
Revised: May 22, 2024
Accepted: June 11, 2024
Published online: July 24, 2024
Processing time: 199 Days and 15.9 Hours

Core Tip

Core Tip: Anaplastic thyroid cancer is an aggressive disease. Surgery is the main treatment. Combination of radiotherapy and chemotherapy help to further improve the outcome of patients with this malignancy. Immunotherapy, targeted therapies, and molecular insights herald a new dawn for a patient cohort hitherto consigned to bleak prognoses.